Q32 Bio (QTTB) Receivables (2018 - 2021)

Q32 Bio (QTTB) recorded quarterly Receivables of $100000.0 in Q3 2021, down 50.0% quarter-over-quarter from $200000.0 in Q2 2021, and down 75.0% on a YoY basis from $400000.0 in Q3 2020.

Q32 Bio (QTTB) Receivables (2018 - 2021) Analysis & Trends

Q32 Bio's Receivables history runs 4 years deep, the most recent figure standing at $100000.0 for Q3 2021.

  • In Q3 2021, Receivables fell 75.0% year-over-year to $100000.0; the TTM figure through Sep 2021 stood at $100000.0 (down 75.0% YoY), while the FY2020 annual figure was $400000.0, changed 0.0% from the prior year.
  • Receivables was $100000.0 for Q3 2021 at Q32 Bio, down from $200000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $800000.0 in Q4 2018 to a low of $100000.0 in Q3 2021.
  • Historically, Receivables has averaged $350000.0 across 4 years, with a median of $350000.0 in 2019.
  • The sharpest annual moves came in 2020 and 2021: Receivables surged 100.0% in 2020, then sank 75.0% in 2021.
  • A 4-year view of Receivables shows it stood at $800000.0 in 2018, then tumbled by 50.0% to $400000.0 in 2019, then changed by 0.0% to $400000.0 in 2020, then tumbled by 75.0% to $100000.0 in 2021.
  • The last three Receivables figures came in at $100000.0 (Q3 2021), $200000.0 (Q2 2021), and $300000.0 (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 13.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.00 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Q32 Bio 167.59 Mn 116.84 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 100,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 300,000.00
Dec 31, 2020 400,000.00
Sep 30, 2020 400,000.00
Jun 30, 2020 400,000.00
Mar 31, 2020 400,000.00
Dec 31, 2019 400,000.00
Sep 30, 2019 300,000.00
Jun 30, 2019 300,000.00
Mar 31, 2019 200,000.00
Dec 31, 2018 800,000.00